Ezaladcigene resoparvovec
- Generic Name
- Ezaladcigene resoparvovec
- Drug Type
- Biotech
- CAS Number
- 2226647-27-2
- Unique Ingredient Identifier
- 2WRS0PE04O
Safety and Efficacy of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes
The PD-1101 trial demonstrates the safety and potential efficacy of VY-AADC01, an AADC gene therapy, in patients with moderately advanced Parkinson disease, showing stable or improved motor function and quality of life over three years.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath